Stavanger University Hospital Inflammatory Bowel Disease Trial
Observational · No treatment assigned · 1 site · Helse Stavanger HF
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: IBD. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 16 to 80
- Any sex
Some of the main requirements, copied from the record:
- newly diagnosed IBD
There are also 3 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 700 participants are expected to take part.
- Start date: 2012-04.
- Main results expected around 2026-12 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Norway.
Main thing being measured
- Clinical efficacy of IBD drug therapy (5 years)
In the researchers’ words
The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | IBD |
| Lead sponsor | Helse Stavanger HF |
| Enrollment | 700 (estimated) |
| Start date | 2012-04 |
| Primary completion (est.) | 2026-12 |
| First posted | 2012-03-12 |
| Last updated | 2025-05-16 |
| Official title | Management of Inflammatory Bowel Disease in the Stavanger Area - a Prospective Evaluation of Standardized Treatment Regimens on Disease Outcome With Focus on Mucosal Healing and Associations to Fatigue |
| ClinicalTrials.gov ID | NCT01551563 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * newly diagnosed IBD Exclusion Criteria: * previous IBD with specific treatment within 10 year * inability to consent * inability to adhere to treatment protocol
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| SUS | Stavanger | Norway | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.